Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
12/2007
12/05/2007EP1862181A2 Combination therapy using an 11B-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
12/05/2007EP1861465A2 Chromophore coated metal oxide particles
12/05/2007EP1861374A1 Carboxanilides as microbiocides
12/05/2007EP1861079A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007CN101084201A Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
12/05/2007CN101084200A 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
12/05/2007CN101083987A S-tryazolyl alpha;-mercaptoacetanliides as inhibitors of HIV reverse transcriptase
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/2007
11/29/2007WO2007135970A1 Heterocyclic type cinnamide derivative
11/29/2007WO2007135969A1 Urea type cinnamide derivative
11/29/2007WO2007134862A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
11/29/2007WO2007134846A2 Process for purification of anastrozole
11/29/2007WO2007134799A1 Novel microbiocides
11/29/2007WO2007134678A2 Triazole derivatives ii
11/29/2007WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007WO2007054963A3 A process for the preparation of pure anastrozole
11/29/2007US20070275965 CXCR4 modulators
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007DE102006024024A1 Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung Substituted Arylimidazolone and -triazolone and their use
11/29/2007CA2652484A1 Heterocyclic type cinnamide derivative
11/29/2007CA2652394A1 Triazole derivatives ii
11/29/2007CA2652375A1 Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same
11/29/2007CA2651396A1 Urea type cinnamide derivative
11/29/2007CA2650795A1 Novel microbiocides
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300934 carbocyclic carboxy nitriles such as 4-chloro-N-[2-({[(1S)-1-cyano-2-thien-3-ylethyl]amino}carbonyl)cyclohexyl]benzamide, used as cathepsin inhibitors; antimetastatic and antitumor agents; prophylaxis of cardiovascular and bone disorders
11/22/2007WO2007132475A1 Selective tr-beta 1 agonist
11/22/2007WO2007105231B1 Improved process for high purity anastrozole
11/22/2007US20070270566 Chain Extenders
11/22/2007US20070270416 Active Compound Combinations Having Insecticidal and Acaricidal Properties
11/22/2007US20070270410 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders
11/22/2007DE102006023337A1 Triazolderivate II Triazole derivatives II
11/22/2007CA2640922A1 Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
11/21/2007EP1857446A1 Novel hsp90 inhibitor
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007EP1855670A2 Benzazole potentiators of metabotropic glutamate receptors
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1339700B1 Process for the preparation of benzotriazoles
11/21/2007CN101074215A Production of 1-[3,5-2(2,2-dimethyl) ethylcyano] benzyl triazole
11/21/2007CN100349879C Process for preparing aryltriazolinones and novel intermediates thereto
11/20/2007US7297802 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides
11/20/2007US7297708 Central nervous system disorders; psychological disorders
11/15/2007WO2007128561A1 Crystalline forms of letrozole and processes for making them
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265318 Estrogen Receptor Modulators
11/14/2007EP1853570A2 Hsp90-inhibiting triazole derivatives
11/14/2007EP1853565A1 Menthane carboxamide derivatives having cooling properties
11/14/2007EP1585541B1 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
11/14/2007CN101072759A Triazole compounds that modulate hsp90 activity
11/14/2007CN101072556A Triazoles useful as inhibitors of protein kinases
11/14/2007CN100348600C Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007CA2248304C Surface modified carbonate materials
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007073503A3 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/08/2007US20070259935 Crystalline forms of letrozole and processes for making them
11/08/2007US20070259854 Triazole Derivative or Salt Thereof
11/07/2007EP1852129A1 Remedy for irritable bowel syndrome
11/07/2007EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007CN101068776A Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066953A Prepn process of letrozole
11/06/2007US7291640 Substituted triazole derivatives as oxytocin antagonists
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007CA2180533C Process for producing aromatic or heteroaromatic sulfur compounds
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007121578A1 Indole amide derivatives as ep4 receptor antagonists
11/01/2007WO2007061923A3 Glucokinase activators
11/01/2007US20070254318 Inhibition of cell proliferation
11/01/2007CA2649628A1 Pharmaceutical product
11/01/2007CA2648729A1 Indole amide derivatives as ep4 receptor antagonists
10/2007
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/25/2007WO2007118903A1 Trisubstituted 1,2,4-triazoles
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070248672 Indole and Azaindole Derivatives with Antitumor Action
10/25/2007DE102006018345A1 Aufhell- und/oder Färbemittel mit Amidinen Reducing and / or coloring with amidines
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007EP1845972A2 Novel heteropyrrole analogs acting on cannabiniod receptors
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244119 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
10/18/2007US20070243416 Amine Compound and Organic Electroluminescent Element Employing the Same
10/18/2007DE102006015704A1 Neue 1,2-Bis-(azol-1-yl)-ethan-1,2-diole als Zwischenprodukte zur Synthese von Agrochemikalien und Verfahren zu ihrer Herstellung New 1,2-bis (azol-1-yl) ethane-1,2-diols as intermediates for the synthesis of agricultural chemicals, and process for their preparation
10/16/2007US7282608 Inhibitors of histone deacetylase
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282590 Drug conjugates
10/16/2007CA2256013C Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
10/11/2007WO2007113634A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007WO2007113327A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 178